Zydus Pharmaceuticals (USA) Inc — FDA Class II (D-0544-2026)

Zydus Pharmaceuticals (USA) Inc is recalling 23,880 bottles of a human prescription drug due to CGMP deviations related to N-Nitros contamination. This recall is classified as a Class II recall. The affected products are distributed in the United States.

• •Zydus Pharmaceuticals is recalling 23,880 bottles of a human prescription drug.
• •The recall is due to contamination with N-Nitros.
• •This is classified as a Class II recall.
• •Consumers should check their medicine cabinets for these products.
• •Contamination with N-Nitros poses potential health risks.

Consumers with the recalled products should stop using them immediately due to contamination risks. The recall affects 23,880 bottles.